West Oak Capital Increased Its Novartis Ag Spon Adr (NVS) Stake; Profile of 7 Analysts Covering CMS Energy (CMS)

Novartis AG (NYSE:NVS) Logo

West Oak Capital Llc increased Novartis Ag Spon Adr (NVS) stake by 0.32% reported in 2018Q1 SEC filing. West Oak Capital Llc acquired 50 shares as Novartis Ag Spon Adr (NVS)’s stock declined 11.54%. The West Oak Capital Llc holds 15,910 shares with $1.29 billion value, up from 15,860 last quarter. Novartis Ag Spon Adr now has $192.75 billion valuation. The stock increased 0.62% or $0.46 during the last trading session, reaching $74.69. About 186,993 shares traded. Novartis AG (NYSE:NVS) has declined 6.45% since June 21, 2017 and is downtrending. It has underperformed by 19.02% the S&P500. Some Historical NVS News: 21/03/2018 – Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc; 09/04/2018 – NOVARTIS AG NOVN.S SAYS DEAL TO TRANSFORM CARE IN SMA AND EXPAND POSITION AS A GENE THERAPY AND NEUROSCIENCE LEADER; 17/05/2018 – Interesting night — The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more $JNCE $LOXO $BPMC $NVS etc; 11/04/2018 – Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira® (adalimumab); 10/05/2018 – Trump plan for drug prices seen largely sparing industry; 17/05/2018 – ROCHE CEO SCHWAN SAYS COMPANY HAS HAD NO CONTACT WITH TRUMP LAWYER COHEN; 04/04/2018 – NOVARTIS GAINED CHF216M FROM SWISS PENSION LAW CHANGE: HZ; 29/03/2018 – Xolair (omalizumab; Roche/Novartis) Drug Analysis 2018 – ResearchAndMarkets.com; 27/03/2018 – Global Human Growth Hormone (hGH) Market Analysis & Outlook 2018-2022 with Profiles of Novartis, Pfizer, Eli Lilly and Co and Novo Nordisk – ResearchAndMarkets.com; 11/05/2018 – MEDIA-Fosun Pharma to vie for $2 bln Novartis portfolio – Bloomberg

Among 17 analysts covering CMS Energy Corporation (NYSE:CMS), 7 have Buy rating, 0 Sell and 10 Hold. Therefore 41% are positive. CMS Energy Corporation had 53 analyst reports since August 31, 2015 according to SRatingsIntel. The stock of CMS Energy Corporation (NYSE:CMS) has “Buy” rating given on Monday, December 18 by Wells Fargo. KeyBanc Capital Markets maintained CMS Energy Corporation (NYSE:CMS) rating on Wednesday, April 18. KeyBanc Capital Markets has “Overweight” rating and $46 target. The stock of CMS Energy Corporation (NYSE:CMS) has “Neutral” rating given on Monday, October 19 by SunTrust. Wells Fargo maintained the shares of CMS in report on Thursday, February 15 with “Buy” rating. As per Wednesday, May 30, the company rating was maintained by KeyBanc Capital Markets. The stock of CMS Energy Corporation (NYSE:CMS) earned “Equal-Weight” rating by Barclays Capital on Friday, March 18. Scotia Capital initiated the shares of CMS in report on Friday, July 15 with “Sector Perform” rating. The stock of CMS Energy Corporation (NYSE:CMS) earned “Neutral” rating by Suntrust Robinson on Monday, October 19. KeyBanc Capital Markets maintained CMS Energy Corporation (NYSE:CMS) on Wednesday, October 18 with “Buy” rating. The rating was maintained by Morgan Stanley on Friday, September 8 with “Equal-Weight”. See CMS Energy Corporation (NYSE:CMS) latest ratings:

13/06/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $47 New Target: $45 Maintain
30/05/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $46 New Target: $47 Maintain
18/04/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $45 New Target: $46 Maintain
16/04/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $45 New Target: $48 Maintain
13/04/2018 Broker: Citigroup Rating: Neutral New Target: $46 Initiates Coverage On
02/04/2018 Broker: SunTrust Rating: Hold New Target: $47.0000 Maintain
26/03/2018 Broker: SunTrust Rating: Hold New Target: $45.0000 Maintain
19/03/2018 Broker: SunTrust Rating: Hold New Target: $46.0 Maintain
08/03/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $46 New Target: $45 Maintain
26/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $48 New Target: $49 Maintain

CMS Energy Corporation operates as an energy firm primarily in Michigan. The company has market cap of $12.73 billion. It operates through three divisions: Electric Utility, Gas Utility, and Enterprises. It has a 25.18 P/E ratio. The Electric Utility segment engages in the generation, purchase, transmission, distribution, and sale of electricity.

The stock decreased 0.17% or $0.075 during the last trading session, reaching $45.04. About 116,727 shares traded. CMS Energy Corporation (NYSE:CMS) has declined 3.78% since June 21, 2017 and is downtrending. It has underperformed by 16.35% the S&P500. Some Historical CMS News: 27/04/2018 – CMS: CMS Drives Patient-Centered Care over Paperwork in Proposals to Modernize Medicare and Reduce Burden; 16/05/2018 – DEEP ECO: CMS Energy May Face Pressure, Industry Falls in April; 20/04/2018 – PTA-CMS: Nexus AG: Release of capital market information – 78. Interim Reporting; 07/03/2018 – CMS: Medicare Provider Reimbursement Manual Part 2, Provider Cost Reporting Forms and Instructions, Chapter 41, Form CMS-2540-1; 16/03/2018 – PTA-CMS: Nexus AG: Release of capital market information – 73. Interim Reporting; 02/04/2018 – Modern Healthcare: #BREAKING: The CMS has finalized a rule giving Medicare Advantage plans a 3.4% pay hike in 2019.…; 02/04/2018 – CMS ISSUES FINAL MEDICARE HEALTH, DRUG PLANS FOR 2019; 10/04/2018 – Admired High School Principal Joins CMS Technology Partners K12 Education Division; 18/05/2018 – PTA-CMS: Nexus AG: Release of capital market information – 82. Interim Reporting; 22/03/2018 – Sen Finance Cmte: Bipartisan, Bicameral Health Committee Leaders Push CMS on Stronger Oversight of the Medicaid Drug Rebate

Another recent and important CMS Energy Corporation (NYSE:CMS) news was published by Prnewswire.com which published an article titled: “CMS Energy Becomes First US Company to Enter Sustainability-Linked Loan” on June 06, 2018.

Investors sentiment decreased to 1.09 in 2018 Q1. Its down 0.31, from 1.4 in 2017Q4. It is negative, as 44 investors sold CMS Energy Corporation shares while 136 reduced holdings. 48 funds opened positions while 149 raised stakes. 235.18 million shares or 0.11% less from 235.44 million shares in 2017Q4 were reported. Lmr Ptnrs Limited Liability Partnership has invested 0.07% in CMS Energy Corporation (NYSE:CMS). Lpl Limited Company invested in 27,283 shares or 0% of the stock. State Treasurer State Of Michigan holds 0.03% or 83,135 shares. Blackrock Inc stated it has 29.02 million shares or 0.06% of all its holdings. 538,300 were reported by Bruce And Inc. Reaves W H And Com reported 868,517 shares or 1.39% of all its holdings. Glenmede Na has invested 0.14% in CMS Energy Corporation (NYSE:CMS). Fdx has invested 0.01% of its portfolio in CMS Energy Corporation (NYSE:CMS). Pictet Asset Management Ltd holds 2.39M shares or 0.27% of its portfolio. Alpine Woods Cap Ltd has invested 0.6% of its portfolio in CMS Energy Corporation (NYSE:CMS). Jnba Finance accumulated 300 shares or 0% of the stock. Personal Capital Advsrs has 0% invested in CMS Energy Corporation (NYSE:CMS) for 4,732 shares. Macquarie Gru stated it has 0.02% in CMS Energy Corporation (NYSE:CMS). Cognios Limited Liability Corp reported 0.92% stake. Gulf Intl State Bank (Uk) Limited reported 87,468 shares.

Among 17 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 9 Hold. Therefore 29% are positive. Novartis Ag has $110 highest and $7700 lowest target. $96.80’s average target is 29.60% above currents $74.69 stock price. Novartis Ag had 38 analyst reports since July 28, 2015 according to SRatingsIntel. HSBC downgraded the shares of NVS in report on Tuesday, May 29 to “Hold” rating. The stock of Novartis AG (NYSE:NVS) has “Buy” rating given on Thursday, November 10 by Argus Research. Citigroup downgraded the stock to “Neutral” rating in Tuesday, March 29 report. The stock of Novartis AG (NYSE:NVS) earned “Underperform” rating by Morgan Stanley on Tuesday, April 12. Cowen & Co maintained the shares of NVS in report on Monday, September 11 with “Hold” rating. Leerink Swann maintained Novartis AG (NYSE:NVS) rating on Thursday, January 25. Leerink Swann has “Market Perform” rating and $100 target. The rating was downgraded by Bank of America on Wednesday, December 6 to “Sell”. The rating was initiated by Argus Research with “Hold” on Tuesday, April 5. Leerink Swann downgraded it to “Market Perform” rating and $85 target in Wednesday, March 23 report. The rating was maintained by JP Morgan with “Neutral” on Friday, March 24.

More notable recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis: Exit Sandoz US Now” on June 06, 2018, also Prnewswire.com with their article: “Developing Technologies for Optical Therapies Aimed At Overcoming Key Challenges in the Healthcare Industry” published on June 21, 2018, Streetinsider.com published: “Novartis (NVS) Granted FDA Approval for Inclusion of New Evidence that Cosentyx (secukinumab) Inhibits Progression …” on June 19, 2018. More interesting news about Novartis AG (NYSE:NVS) were released by: Seekingalpha.com and their article: “Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery” published on June 19, 2018 as well as Fool.com‘s news article titled: “5 Experimental New Drugs That Could Be Worth $47 Billion” with publication date: June 20, 2018.

CMS Energy Corporation (NYSE:CMS) Institutional Positions Chart